CytoSorbents

Directions Website

CytoSorbents CytoSorbents Corporation is a critical care focused immunotherapy company using blood purification t

CytoSorbents Corporation (NASDAQ: CTSO) is a New Jersey-based company involved in the R&D and commercialization of medical devices using its proprietary polymer adsorption technology.

CytoSorbents is a leader in the treatment of life-threatening conditions in the ICU and cardiac surgery using blood purification. Its flagship product, CytoSorb®, is distributed in more than 70 countries and has CE Mark approval in the EU for cytokine, bilirubin and myoglobin removal in numerous critical care applications and the removal of ticagrelor and rivaroxaban during cardiothoracic surgery.

CytoSorbents has multiple active, clinical trials ongoing, including two pivotal randomized, controlled trials in the United States designed to support eventual FDA marketing approval for antithrombotic removal during cardiothoracic surgery using the DrugSorb™-ATR Antithrombotic Removal System.

🔥 Campfire beim DIVI-Kongress 2026: Erfahrungen diskutieren, Erkenntnisse teilen.Welche Erfahrungen liegen zum Einsatz d...
11/04/2026

🔥 Campfire beim DIVI-Kongress 2026: Erfahrungen diskutieren, Erkenntnisse teilen.

Welche Erfahrungen liegen zum Einsatz der Hämoadsorption mit CytoSorb beim septischen Schock vor? Welche Erkenntnisse haben wir gewonnen und wo besteht weiterer Verbesserungsbedarf?

Diesen Fragen widmen wir uns bei unserem Campfire:

• Donnerstag, 03.12.2026 | 14:00–14:30 Uhr
• Hemoadsorption mit CytoSorb beim septischen Schock – was wir gelernt haben und verbessern sollten
• Dr. Moritz Unglaube, Wiesbaden und PD Dr. Gerd Klinkmann, Rostock

Sie möchten sich darüber hinaus über die CytoSorb Therapie, HotSwap oder PuriFi informieren? Besuchen Sie uns an unserem Stand. Wir freuen uns auf Ihre Teilnahme und den fachlichen Austausch!

đź’ˇ Beyond mechanical support: Hemoadsorption in advanced heart failureJoin us for an expert webinar exploring two importa...
11/02/2026

đź’ˇ Beyond mechanical support: Hemoadsorption in advanced heart failure

Join us for an expert webinar exploring two important topics in advanced cardiac care: hemoadsorption in the context of ECMO and current treatment options for vasoplegia following LVAD implantation.

The webinar, moderated by Prof. Daniel Wendt, features two expert presentations:

• When ECMO needs hemoadsorption – rationale, evidence, outlook
Prof. Federico Pappalardo, Italy

• Vasoplegia after LVAD implantation – current treatment options
Dr. Nandor Marczin, UK

đź“… November 18, 2026
🕔 5:00–6:00 PM CET

👉 Register now: cyto.news/webinar-cardiac/nov18/eng

Not long to go until SCPS 2026! 🇬🇧We are getting ready for the Annual SCPS Congress in Nottingham, UK and are looking fo...
10/27/2026

Not long to go until SCPS 2026! 🇬🇧

We are getting ready for the Annual SCPS Congress in Nottingham, UK and are looking forward to three days of scientific exchange, new perspectives and valuable conversations with the perfusion community.

The congress is a great opportunity to connect, share experiences and discuss current topics in perfusion and cardiac surgery.

If you are attending, make sure to stop by booth no. 8 and meet the CytoSorbents UK team. We look forward to seeing you in Nottingham!

📅 6–8 November 2026
📍 East Midlands Conference Centre, Nottingham
📌 Booth No. 8

What role does hemoadsorption play in the context of advanced heart failure and mechanical circulatory support?Join us f...
10/26/2026

What role does hemoadsorption play in the context of advanced heart failure and mechanical circulatory support?

Join us for an expert webinar exploring the rationale, available evidence, and future perspectives on hemoadsorption in the context of ECMO, alongside current treatment options for vasoplegia following LVAD implantation.

đź“… November 18, 2026
🕔 5:00–6:00 PM CET

Beyond mechanical support: Hemoadsorption in advanced heart failure
Moderator: Prof. Daniel Wendt, CytoSorbents Europe

• When ECMO needs hemoadsorption – rationale, evidence, outlook
Prof. Federico Pappalardo, Italy

• Vasoplegia after LVAD implantation – current treatment options
Dr. Nandor Marczin, UK

👉 Register now: cyto.news/webinar-cardiac/nov18/eng

  that William Stewart Halsted (1852–1922) was an American surgeon and a pioneer of modern scientific surgery?As a co-fo...
10/20/2026

that William Stewart Halsted (1852–1922) was an American surgeon and a pioneer of modern scientific surgery?

As a co-founder of the Johns Hopkins University School of Medicine, Halsted helped shape modern surgical education by establishing a structured residency training system that emphasized hands-on experience, close supervision, and progressive responsibility. He also contributed to the advancement of aseptic surgical practices, including the introduction of surgical gloves. His emphasis on meticulous surgical technique, careful tissue handling, and systematic training had a lasting influence on surgical education and practice, helping shape the foundations of modern surgery.

📍 CytoSorbents auf dem DIVI – wir freuen uns auf den Austausch!Besuchen Sie uns auf dem Kongress der Deutschen Interdisz...
10/14/2026

📍 CytoSorbents auf dem DIVI – wir freuen uns auf den Austausch!

Besuchen Sie uns auf dem Kongress der Deutschen Interdisziplinären Vereinigung für Intensiv- und Notfallmedizin (DIVI) in Hamburg vom 02. bis 04.12.2026 und informieren Sie sich an unserem Stand über unsere Produkte und Technologien für die Intensivmedizin sowie deren Einsatzmöglichkeiten in der klinischen Praxis.

🔥 Merken Sie sich außerdem schon heute unser Campfire am Donnerstag, 03.12.2026 von 14:00 bis 14:30 Uhr vor zum Thema:

Hemoadsorption mit CytoSorb beim septischen Schock – was wir gelernt haben und verbessern sollten

🎙️Dr. Moritz Unglaube, Wiesbaden
🎙️PD Dr. Gerd Klinkmann, Rostock

Wir freuen uns auf den fachlichen Austausch!

Aufzeichnung online! Das Webinar „Untersuchungs- und Behandlungsmethoden: Wirtschaftlichkeit, Qualitätsgebot & aktuelle ...
10/09/2026

Aufzeichnung online! Das Webinar „Untersuchungs- und Behandlungsmethoden: Wirtschaftlichkeit, Qualitätsgebot & aktuelle Rechtsprechung“ können Sie jetzt nachträglich ansehen.

Themen:
• aktuelle Rechtsprechung zu innovativen Untersuchungs- und Behandlungsmethoden
• medizinische Grundlagen und aktuelle Entwicklungen zur Hämoadsorption mit CytoSorb
• die Abbildung der Hämoadsorption im aG-DRG-System

mit:
• Dr. iur. Christian Rybak, Partner/Shareholder, Chair Health Care & Life Sciences Germany, Greenberg Traurig Germany, LLP
• Dr. med. Volker Humbert, Senior Director Medical, CytoSorbents Europe
• Franziska Preissing, Senior Director Reimbursement Germany, CytoSorbents Europe

Jetzt Aufzeichnung ansehen und Praxiswissen sichern: https://cyto.news/medcon/sept2026

We are heading to Nottingham! 🇬🇧The CytoSorbents UK team is looking forward to joining the 52nd Annual Congress of the S...
10/07/2026

We are heading to Nottingham! 🇬🇧

The CytoSorbents UK team is looking forward to joining the 52nd Annual Congress of the Society of Clinical Perfusion Scientists of Great Britain & Ireland (SCPS) this November.

The congress brings together the perfusion community for three days of scientific exchange, continuing education and discussion around current developments in perfusion and cardiothoracic care.

We look forward to connecting with perfusionists, healthcare professionals and industry colleagues throughout the meeting.

📅 6–8 November 2026
📍 East Midlands Conference Centre, Nottingham

Attending SCPS 2026? Come and meet the CytoSorbents team in the exhibition area – we look forward to seeing you there!

Address

305 College Road East
Princeton, NJ
08540

Alerts

Be the first to know and let us send you an email when CytoSorbents posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Nearby clinics


Other Medical Equipment Suppliers in Princeton

Show All